top of page
Unlock the Latest Industry Insights
Subscribe to our newsletter to remain informed.
We will provide you with crucial industry information and ensure that you are up-to-date on the most recent events that you would not want to overlook.
Top 5 Digital Health Innovations: Why Only 20% of Clinical Trials Succeed
Digital health innovations are transforming clinical research, offering new tools and methodologies to enhance the efficiency and...
BioBoston Consulting
Jul 9, 20242 min read
Top 3 Market Access Challenges: Only 15% of Emerging Therapies Succeed
The biopharmaceutical landscape is constantly evolving, with new therapies emerging at a rapid pace. Despite the influx of innovation,...
BioBoston Consulting
Jul 8, 20242 min read
Top 5 Challenges in Drug Repurposing: Why Only 15% of Trials Succeed
Drug repurposing, the process of finding new uses for existing medications, offers a promising avenue to accelerate the availability of...
BioBoston Consulting
Jul 5, 20242 min read
Top 5 Alarming Stats You Need to Know About Privacy vs. Openness
In today's era of rapid medical advancements and digital transformation, the balance between clinical data transparency and patient...
BioBoston Consulting
Jul 4, 20243 min read
5 Key Strategies to Communicate Value in Biotech Investor Relations
Effective communication with investors is crucial for biotech companies aiming to secure funding, build trust, and demonstrate progress....
BioBoston Consulting
Jul 3, 20242 min read
Top 5 HEOR Stats Impacting Drug Development
Health Economics and Outcomes Research (HEOR) is a critical component in the pharmaceutical and biotechnology sectors, influencing...
BioBoston Consulting
Jul 2, 20242 min read
Why 80% of Life Sciences Startups Fail to Protect Their Innovations
In the competitive and fast-paced world of life sciences, safeguarding intellectual property (IP) is crucial for the survival and success...
BioBoston Consulting
Jul 1, 20243 min read
Top 5 Challenges in Cross-Functional Team Leadership
Leading a cross-functional team, especially in clinical operations within the biotech, pharma, and life sciences industries, is a...
BioBoston Consulting
Jun 28, 20242 min read
Avoid the 80% Failure Rate in Preclinical Stages
Biotech startups, particularly those in the preclinical stages, face a notoriously high failure rate, with approximately 80% never...
BioBoston Consulting
Jun 27, 20242 min read
Why Less Than 20% of Clinical Research Takes Full Advantage
Adaptive trial designs have revolutionized the landscape of clinical research by offering unprecedented flexibility and efficiency....
BioBoston Consulting
Jun 26, 20242 min read
Only 15% Succeed: Top 5 Critical Challenges of Cell Therapy from Lab to Market
Cell therapy has emerged as a promising frontier in modern medicine, offering potential cures for a range of diseases from cancer to...
BioBoston Consulting
Jun 25, 20242 min read
bottom of page